These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34624627)

  • 21. Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase.
    Choughule KV; Joswig-Jones CA; Jones JP
    Biochem Pharmacol; 2015 Aug; 96(3):288-95. PubMed ID: 26032640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Utility of Chimeric Mice with Humanized Livers for the Characterization and Profiling of the Metabolites of a Selective Inhibitor (YM543) of the Sodium-Glucose Cotransporter 2.
    Nakada N
    Pharm Res; 2017 Apr; 34(4):874-886. PubMed ID: 28194636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues.
    Hammid A; Fallon JK; Vellonen KS; Lassila T; Reinisalo M; Urtti A; Gonzalez F; Tolonen A; Smith PC; Honkakoski P
    Eur J Pharm Sci; 2023 Dec; 191():106603. PubMed ID: 37827455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimeric mice with humanized liver.
    Katoh M; Tateno C; Yoshizato K; Yokoi T
    Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor.
    Zhang X; Liu HH; Weller P; Zheng M; Tao W; Wang J; Liao G; Monshouwer M; Peltz G
    Pharmacogenomics J; 2011 Feb; 11(1):15-24. PubMed ID: 20177421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.
    Akabane T; Tanaka K; Irie M; Terashita S; Teramura T
    Xenobiotica; 2011 May; 41(5):372-84. PubMed ID: 21385103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
    Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
    Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of desloratadine by chimeric TK-NOG mice transplanted with human hepatocytes.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Xenobiotica; 2020 Jun; 50(6):733-740. PubMed ID: 31690163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
    Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
    Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nimesulide increases the aldehyde oxidase activity of humans and rats.
    Zhou L; Pang XY; Hou XY; Liu L; Guo ZT; Chen XY
    Acta Pharmacol Sin; 2020 Jun; 41(6):843-851. PubMed ID: 31913347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective Na
    Asano D; Nakamura K; Nishiya Y; Shiozawa H; Takakusa H; Shibayama T; Inoue SI; Shinozuka T; Hamada T; Yahara C; Watanabe N; Yoshinari K
    Drug Metab Dispos; 2023 Jan; 51(1):67-80. PubMed ID: 36273823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simulation of human plasma concentration-time profiles of the partial glucokinase activator PF-04937319 and its disproportionate N-demethylated metabolite using humanized chimeric mice and semi-physiological pharmacokinetic modeling.
    Kamimura H; Ito S; Chijiwa H; Okuzono T; Ishiguro T; Yamamoto Y; Nishinoaki S; Ninomiya SI; Mitsui M; Kalgutkar AS; Yamazaki H; Suemizu H
    Xenobiotica; 2017 May; 47(5):382-393. PubMed ID: 27389028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline.
    Paragas EM; Humphreys SC; Min J; Joswig-Jones CA; Jones JP
    Biochem Pharmacol; 2017 Dec; 145():210-217. PubMed ID: 28888950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase.
    Inoue K; Mizuo H; Kawaguchi S; Fukuda K; Kusano K; Yoshimura T
    Drug Metab Dispos; 2014 Aug; 42(8):1326-33. PubMed ID: 24914245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of primary oxidative metabolites of thalidomide in rats and in chimeric mice humanized with different human hepatocytes.
    Miura T; Uehara S; Shimizu M; Suemizu H; Yamazaki H
    J Toxicol Sci; 2021; 46(7):311-317. PubMed ID: 34193768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5.
    Morrison RD; Blobaum AL; Byers FW; Santomango TS; Bridges TM; Stec D; Brewer KA; Sanchez-Ponce R; Corlew MM; Rush R; Felts AS; Manka J; Bates BS; Venable DF; Rodriguez AL; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2012 Sep; 40(9):1834-45. PubMed ID: 22711749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics.
    Sanoh S; Ohta S
    Biopharm Drug Dispos; 2014 Mar; 35(2):71-86. PubMed ID: 24114658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldehyde oxidase importance in vivo in xenobiotic metabolism: imidacloprid nitroreduction in mice.
    Swenson TL; Casida JE
    Toxicol Sci; 2013 May; 133(1):22-8. PubMed ID: 23462233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro-In Vivo Comparisons.
    Wilkinson DJ; Southall RL; Li M; Wright LM; Corfield LJ; Heeley TA; Bratby B; Mannu R; Johnson SL; Shaw V; Friett HL; Blakeburn LA; Kendrick JS; Otteneder MB
    AAPS J; 2017 Jul; 19(4):1163-1174. PubMed ID: 28474310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
    Strelevitz TJ; Orozco CC; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.